Summary
Lithium administered to rats did not interfere with the transfer rate of radioactive sodium from blood to brain tissue.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amdisen, A.: Serum lithium determinations for clinical use. Scand. J. clin. Lab. Invest. 20, 104–108 (1967).
Baastrup, P. C., and M. Schou: Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch. gen. Psychiat. 16, 162–172 (1967).
Coppen, A. J.: Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness. J. Neurol. Neurosurg. Psychiat. 23, 156–161 (1960).
Fotherby, K., G. W. Ashcroft, J. W. Affleck, and A. D. Forrest: Studies on sodium transfer and 5-hydroxyindoles in depressive illness. J. Neurol. Neurosurg. Psychiat. 26, 71–73 (1963).
Schou, M.: Lithium studies. 3. Distribution between serum and tissues. Acta pharmacol. (Kbh.) 15, 115–124 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amdisen, A., Schou, M. Lithium and the transfer rate of sodium across the blood-brain barrier. Psychopharmacologia 12, 236–238 (1968). https://doi.org/10.1007/BF00403777
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403777